Skip to main content
SHIELD THERAPEUTICS PLC logo

SHIELD THERAPEUTICS PLC — Investor Relations & Filings

Ticker · STX ISIN · GB00BYV81293 LEI · 213800G74QWY15FC3W71 IL Manufacturing
Open in API
Filings indexed 409 across all filing types
Latest filing 2018-10-01 Regulatory Filings
Country GB United Kingdom
Listing IL STX

About SHIELD THERAPEUTICS PLC

https://www.shieldtherapeutics.com/

Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on addressing iron deficiency. The company's mission is to improve the lives of patients suffering from this condition, with or without anemia. Its lead product is Accrufer® (ferric maltol), also marketed as Feraccru®, a novel, stable, non-salt-based oral therapy. This innovative pharmaceutical is broadly indicated for use in adults across multiple therapeutic categories, aiming to provide an effective and well-tolerated treatment for a significant unmet medical need.

Recent filings

Filing Released Lang Actions
Submission of an NDA for Feraccru® with the FDA
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 4323C' and is dated October 1, 2018. The content is a press release announcing a significant corporate event: the submission of a New Drug Application (NDA) for Feraccru® to the US Food and Drug Administration (FDA). This type of announcement, which details regulatory milestones, business progress, and includes forward-looking statements, is characteristic of a general regulatory news release disseminated via services like RNS (Regulatory News Service). Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a dividend notice (DIV), the most appropriate classification is the general regulatory announcement category, RNS.
2018-10-01 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document begins with an 'RNS Number' and is dated September 24, 2018. The content explicitly details a transaction where the CEO, Carl Sterritt, acquired shares, and it includes a formal 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them' table, referencing the EU Market Abuse Regulation. This structure is characteristic of insider trading disclosures or director's dealings reports filed via regulatory news services. The specific definition matching the disclosure of personal share transactions by directors/executives is 'Director's Dealing' (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2018-09-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document explicitly starts with 'RNS Number : 7253B' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). However, the document is clearly distributed via RNS (Regulatory News Service) and is a standardized regulatory filing format (TR-1). Given the options, 'MRQ' (Major Shareholding Notification) is the most specific content classification, but since it is a formal regulatory announcement distributed via the RNS system, and the content is a specific type of insider/major holder disclosure, MRQ is the best fit for the *content*. If the content were generic, RNS would be the fallback. Since MRQ is an available specific code, I will use it.
2018-09-24 English
AEGIS-H2H Completion of Recruitment
Legal Proceedings Report Classification · 99% confidence The document begins with 'RNS Number : 6197A' and contains information about a clinical trial update ('Shield reports completion of recruitment to AEGIS Head to Head Study'). It is a press release format announcing a specific operational/clinical milestone, which is typical for regulatory news services like RNS (London Stock Exchange). Since it is a general announcement of company news that doesn't fit the specific categories like ER (Earnings Release), IR (Interim Report), or CAP (Financing Update), the most appropriate classification is the general regulatory announcement category, RNS.
2018-09-13 English
Appointment of Non-Executive Director
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated July 26, 2018. The content explicitly announces the 'Appointment of Non-Executive Director' and includes required regulatory disclosures pursuant to AIM Rules, detailing the director's age and past/current directorships. This type of announcement, concerning changes in senior management or board composition, directly maps to the Board/Management Information category (MANG). Although it is distributed via RNS, the specific content is about management change, making MANG the most precise classification.
2018-07-26 English
Holdings in Company
Major Shareholding Notification Classification · 98% confidence The document explicitly contains the header 'RNS Number : 0683U' and mentions 'This information is provided by RNS, the news service of the London Stock Exchange.' The content is a 'TR-1: Standard form for notification of major holdings,' which details changes in share ownership thresholds. This type of mandatory regulatory disclosure, especially when sourced directly from RNS, falls under the general category for regulatory announcements that do not fit a more specific financial report type. Since 'Major Shareholding Notification' (MRQ) is a specific category, and this form (TR-1) is a standard regulatory filing notification, it fits best under the general 'Regulatory Filings' (RNS) category, as it is a notification rather than a comprehensive report like a 10-K or IR. However, given the specific nature of the content (TR-1 for major holdings), MRQ is a strong candidate. Let's re-evaluate the definitions. MRQ is defined as 'Notification of changes in significant share ownership levels (crossing thresholds).' The TR-1 form is precisely this. Therefore, MRQ is the most accurate classification.
2018-07-09 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.